Trial NCT04458909

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2020-04581
Secondary IDs: NCI-2020-04581 NRG-HN007 U10CA180868

Last trial update was posted on 2024-01-22

MeSH Interventions

Carboplatin Cisplatin Gemcitabine Nivolumab

MeSH Conditions

Carcinoma Carcinoma, Squamous Cell Nasopharyngeal Carcinoma Recurrence

Other Conditions

Metastatic Nasopharyngeal Carcinoma Metastatic Nasopharyngeal Keratinizing Squamous Cell Carcinoma Metastatic Nasopharyngeal Nonkeratinizing Carcinoma Metastatic Nasopharyngeal Undifferentiated Carcinoma Nasopharyngeal Nonkeratinizing Carcinoma Recurrent Nasopharyngeal Carcinoma Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma Recurrent Nasopharyngeal Undifferentiated Carcinoma Stage IV Nasopharyngeal Carcinoma AJCC v8 Stage IVA Nasopharyngeal Carcinoma AJCC v8 Stage IVB Nasopharyngeal Carcinoma AJCC v8

Stopping Reasons

External information

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID